Y Intercept Hong Kong Ltd Takes Position in Molina Healthcare, Inc $MOH

Y Intercept Hong Kong Ltd purchased a new position in shares of Molina Healthcare, Inc (NYSE:MOH) in the 1st quarter, Holdings Channel.com reports. The institutional investor purchased 6,855 shares of the company’s stock, valued at approximately $914,000.

Several other large investors also recently added to or reduced their stakes in the company. Torren Management LLC bought a new stake in Molina Healthcare in the 4th quarter valued at about $26,000. Miller Global Investments LLC bought a new position in Molina Healthcare during the fourth quarter worth about $27,000. Physician Wealth Advisors Inc. boosted its position in Molina Healthcare by 1,250.0% during the first quarter. Physician Wealth Advisors Inc. now owns 216 shares of the company’s stock worth $29,000 after purchasing an additional 200 shares during the period. Cromwell Holdings LLC increased its stake in shares of Molina Healthcare by 211.9% in the fourth quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock worth $32,000 after purchasing an additional 125 shares in the last quarter. Finally, Quarry LP purchased a new position in shares of Molina Healthcare in the fourth quarter worth about $32,000. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on MOH shares. Truist Financial boosted their price target on shares of Molina Healthcare from $180.00 to $205.00 and gave the company a “hold” rating in a research report on Monday, May 11th. Robert W. Baird lifted their price objective on shares of Molina Healthcare from $124.00 to $163.00 and gave the company a “neutral” rating in a research note on Monday, May 11th. Royal Bank Of Canada lifted their price objective on shares of Molina Healthcare from $216.00 to $248.00 and gave the company a “sector perform” rating in a research note on Thursday. Cantor Fitzgerald boosted their target price on shares of Molina Healthcare from $144.00 to $209.00 and gave the company a “neutral” rating in a report on Monday, May 11th. Finally, Barclays dropped their target price on Molina Healthcare from $199.00 to $184.00 and set an “underweight” rating on the stock in a research report on Wednesday. Three research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Molina Healthcare currently has a consensus rating of “Hold” and an average price target of $185.88.

Insider Buying and Selling

In other Molina Healthcare news, CAO Maurice Hebert sold 600 shares of the firm’s stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $191.55, for a total value of $114,930.00. Following the completion of the transaction, the chief accounting officer directly owned 12,815 shares of the company’s stock, valued at $2,454,713.25. This trade represents a 4.47% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Jeff D. Barlow sold 17,811 shares of the business’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the transaction, the insider owned 67,175 shares of the company’s stock, valued at $12,502,611. This trade represents a 20.96% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 1.44% of the company’s stock.

Molina Healthcare Trading Down 0.6%

Shares of MOH opened at $231.94 on Monday. The business’s 50-day moving average price is $199.29 and its 200-day moving average price is $173.15. Molina Healthcare, Inc has a twelve month low of $121.06 and a twelve month high of $243.50. The stock has a market cap of $12.08 billion, a PE ratio of 68.62 and a beta of 0.74. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.97.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.57 by $0.78. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The firm had revenue of $10.80 billion for the quarter, compared to the consensus estimate of $10.91 billion. During the same period in the prior year, the firm posted $6.08 earnings per share. The company’s revenue for the quarter was down 3.1% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. On average, equities analysts forecast that Molina Healthcare, Inc will post 5.23 EPS for the current fiscal year.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.